Oncometabolites: linking altered metabolism with cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23999438.
- Also identified by DOI 10.1172/JCI67228 and PMC identifier 3754247.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The discovery of cancer-associated mutations in genes encoding key metabolic enzymes has provided a direct link between altered metabolism and cancer. Advances in mass spectrometry and nuclear magnetic resonance technologies have facilitated high-resolution metabolite profiling of cells and tumors and identified the accumulation of metabolites associated with specific gene defects. Here we review the potential roles of such "oncometabolites" in tumor evolution and as clinical biomarkers for the detection of cancers characterized by metabolic dysregulation.
Medical subject headings
- Biomarkers, Tumor
- Carboxylic Acids
- Neoplasms